Company intelligence / Profile preview

Cryonove Pharma

Chartres, Centre-Val de Loire, Francecryonovepharma.com ↗

Ownership: Private
Development stage: Other

Overview

Cryonove Pharma has developed a proprietary platform of medical devices based on oscillatory thermal shocks at positive temperatures, with CE-marked products already commercialized in Europe for the treatment of brown spots on the hands. Ongoing clinical studies are evaluating further applications, including facial lentigines and post-inflammatory hyperpigmentation. The technology is protected by several global patents, with additional filings underway. Early results indicate good tolerance and performance in targeted dermatological conditions.

Therapeutic areas: Dermatology
Modalities: Device
Industry: Therapeutic Medical Devices

Partnerships

Go Capital Loire Valley Invest Fund investor/partner since December 2018

Beyond the preview

Go deeper on Cryonove Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cryonove Pharma.

Explore the full profile